| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.20B | +18.3% |
| Cost of Revenue | $2.47B | +20.4% |
| R&D Expense | $13.9M | +85.4% |
| SG&A Expense | $394.4M | +23.8% |
| Operating Income | $404.5M | +6.3% |
| Interest Expense | $4.5M | +121.7% |
| Pre-tax Income | $398.1M | +14.2% |
| Income Tax | $68.3M | +2.8% |
| Net Income | $328.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $499.8M | +574.4% |
| Accounts Receivable | $220.4M | +122.4% |
| Inventory | $46.5M | +15.5% |
| Current Assets | $1.56B | +67.8% |
| Total Assets | $4.27B | +48.8% |
| Current Liabilities | $672.0M | +41.7% |
| Long-term Debt | $2.02B | +93.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $479.8M | +17.5% |
| Capital Expenditures | $184.6M | +20.1% |
| Investing Cash Flow | -$742.1M | -380.1% |
| Financing Cash Flow | $693.6M | +374.4% |
| Free Cash Flow | $295.3M | +15.9% |
| +16.7% |
| EPS (Basic) | $3.59 | +16.6% |
| EPS (Diluted) | $3.58 | +16.6% |
| Total Liabilities |
| $3.04B |
| +69.8% |
| Stockholders' Equity | $1.23B | +14.0% |